Koji Nagafuji

发表

Effect of graft-versus-host disease on outcomes of HLA-haploidentical peripheral blood transplantation using post-transplant cyclophophamide

J. Kanda, Y. Atsuta, Y. Akahoshi, 2023, Bone marrow transplantation.

Effect of related donor availability on outcome of AML in the context of related and unrelated hematopoietic cell transplantation

N. Emi, I. Miura, S. Miyawaki, 2013, Bone Marrow Transplantation.

Prognostic factors in haploidentical transplantation with post-transplant cyclophosphamide for acute myeloid leukemia.

M. Onizuka, T. Kondo, Y. Atsuta, 2024, Cytotherapy.

Expansion of donor-reactive host T cells in primary graft failure after allogeneic hematopoietic SCT following reduced-intensity conditioning

K. Akashi, H. Iwasaki, T. Miyamoto, 2014, Bone Marrow Transplantation.

Autologous HSCT with novel agent‐based induction and consolidation followed by lenalidomide maintenance for untreated multiple myeloma

T. Miyamoto, Y. Mori, J. Kuroda, 2024, Cancer science.

Peripheral blood stem cell transplantation using HLA-haploidentical donor with post-transplant cyclophosphamide versus HLA-matched sibling donor for lymphoma.

S. Kako, T. Ichinohe, Y. Atsuta, 2024, Bone marrow transplantation.

Prognostic impact of HLA supertype mismatch in single-unit cord blood transplantation.

T. Miyamoto, Y. Kunisaki, K. Miyawaki, 2024, Bone marrow transplantation.

PBSC collection from family donors in Japan: a prospective survey

N. Schmitz, H. Dohy, K. Kawa, 2014, Bone Marrow Transplantation.